NPCE

NPCE · Neuropace Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Keybanc Initiates Coverage on NeuroPace (NPCE) with Overweight Rating. Keybanc has started coverage of NeuroPace, giving it an overweight rating and a price target of $18. This follows the recent average analyst target of $20, which sits near the top of the 52‑week range of $9.22 to $19.60. The new rating adds to the company's positive outlook as it trades near its support level of $14.01 with an RSI of 41.9.

this person other insiders at NPCE

Insiders & Stakes

Accelmed Partners II L.P.
10% Owner
4,432,948
Shares held
ORBIMED ADVISORS LLC
Director
3,238,199
Shares held
Frank M. Fischer
Director
599,534
Shares held
Favet Michael
Chief Executive Officer
407,080
Shares held
Ridley Irina
General Counsel and Secretary
141,139
Shares held
Joel Becker
CHIEF EXECUTIVE OFFICER
138,000
Shares held
Kuhn Rebecca
Chief Financial Officer
131,613
Shares held
Patrick F. Williams
Chief Financial Officer
67,508
Shares held
Martha Morrell
CHIEF MEDICAL OFFICER
51,357
Shares held
Rakhi Kumar
Chief Accounting Officer
23,039
Shares held
Uri Geiger18,537
Shares held
Joseph Lacob
Director
14,754
Shares held
R. Scott Huennekens
Director
2,890
Shares held
Renee Ryan
Director
2,890
Shares held
Lisa Andrade
Director
2,890
Shares held
KCK LTD.0
Shares held

Transaction History

Martha Morrell▼ Sell$5K
Patrick F. Williams▼ Sell$17K
Joel Becker▼ Sell$19K
Joel Becker▼ Sell$16K
Martha Morrell▼ Sell$5K
Martha Morrell▼ Sell$5K
Rakhi Kumar▲ Buy$15K
Uri Geiger▲ Buy$12K
Frank M. Fischer▲ Buy$23K
Frank M. Fischer▲ Buy$0
R. Scott Huennekens▲ Buy$0
Uri Geiger▲ Buy$0
Rakhi Kumar▲ Buy$0
Renee Ryan▲ Buy$0
Lisa Andrade▲ Buy$0
Joel Becker▼ Sell$20K
Joel Becker▼ Sell$19K
Martha Morrell▼ Sell$6K
Patrick F. Williams▲ Buy$0
Martha Morrell▲ Buy$0
Joel Becker▲ Buy$0
Martha Morrell▼ Sell$18K
Uri Geiger▲ Buy$12K
Joseph Lacob▲ Buy$11K
Rakhi Kumar▲ Buy$15K
Frank M. Fischer▲ Buy$24K
Martha Morrell▼ Sell$19K
Joel Becker▼ Sell$69K
Joel Becker▼ Sell$16K
Martha Morrell▼ Sell$5K
Martha Morrell▼ Sell$49K
Rakhi Kumar▲ Buy$15K
Uri Geiger▲ Buy$12K
Frank M. Fischer▲ Buy$24K
Joseph Lacob▲ Buy$11K
Martha Morrell▼ Sell$399K
Martha Morrell▼ Sell$22K
Joel Becker▼ Sell$19K
Martha Morrell▼ Sell$6K
Martha Morrell▼ Sell$41K
Uri Geiger▲ Buy$12K
Joseph Lacob▲ Buy$11K
Rakhi Kumar▲ Buy$15K
Frank M. Fischer▲ Buy$24K
Martha Morrell▼ Sell$13K
Joel Becker▼ Sell$10K
Martha Morrell▼ Sell$3K
Martha Morrell▼ Sell$26K
Joseph Lacob▲ Buy$11K
Uri Geiger▲ Buy$12K
Rakhi Kumar▲ Buy$15K
Frank M. Fischer▲ Buy$24K
Patrick F. Williams▲ Buy$0
Kuhn Rebecca▼ Sell$18K
Martha Morrell▼ Sell$18K
Joel Becker▼ Sell$14K
Kuhn Rebecca▼ Sell$5K
Martha Morrell▼ Sell$5K
Kuhn Rebecca▼ Sell$55K
Martha Morrell▼ Sell$55K
ORBIMED ADVISORS LLC▼ Sell$2.1M
ORBIMED ADVISORS LLC▼ Sell$542K
Martha Morrell▼ Sell$3K
Kuhn Rebecca▼ Sell$3K
Martha Morrell▲ Buy$0
Rakhi Kumar▲ Buy$15K
Frank M. Fischer▲ Buy$24K
Uri Geiger▲ Buy$12K
Joseph Lacob▲ Buy$11K
Joel Becker▲ Buy$0
Kuhn Rebecca▲ Buy$0
Martha Morrell▼ Sell$16K
Kuhn Rebecca▼ Sell$16K
Joel Becker▼ Sell$57K
Kuhn Rebecca▼ Sell$18K
Martha Morrell▼ Sell$18K
Martha Morrell▼ Sell$1.1M
Martha Morrell▼ Sell$48K
Kuhn Rebecca▼ Sell$48K
KCK LTD.▼ Sell$49.5M
Martha Morrell▼ Sell$3K
Martha Morrell▼ Sell$2K
Martha Morrell▼ Sell$48K
Martha Morrell▼ Sell$4K
Kuhn Rebecca▼ Sell$4K
Rakhi Kumar▲ Buy$15K
Joseph Lacob▲ Buy$11K
Frank M. Fischer▲ Buy$24K
Uri Geiger▲ Buy$12K
Martha Morrell▼ Sell$17K
Kuhn Rebecca▼ Sell$16K
Martha Morrell▼ Sell$28K
Kuhn Rebecca▼ Sell$28K
KCK LTD.▼ Sell$1.2M
KCK LTD.▼ Sell$885
Martha Morrell▼ Sell$1K
Kuhn Rebecca▼ Sell$1K
KCK LTD.▼ Sell$25K
KCK LTD.▼ Sell$23K
KCK LTD.▼ Sell$31K
KCK LTD.▼ Sell$21K
KCK LTD.▼ Sell$45K
KCK LTD.▼ Sell$26K
KCK LTD.▼ Sell$26K
KCK LTD.▼ Sell$16K
KCK LTD.▼ Sell$15K
KCK LTD.▼ Sell$19K
KCK LTD.▼ Sell$39K
KCK LTD.▼ Sell$33K
KCK LTD.▼ Sell$40K
KCK LTD.▼ Sell$23K
KCK LTD.▼ Sell$26K
KCK LTD.▼ Sell$33K
Frank M. Fischer▲ Buy$24K
Uri Geiger▲ Buy$12K
Rakhi Kumar▲ Buy$15K
KCK LTD.▼ Sell$32K
Joseph Lacob▲ Buy$11K
KCK LTD.▼ Sell$34K
KCK LTD.▼ Sell$39K
KCK LTD.▼ Sell$39K
KCK LTD.▼ Sell$2K
KCK LTD.▼ Sell$6K
KCK LTD.▼ Sell$15K
KCK LTD.▼ Sell$83
KCK LTD.▼ Sell$105
Martha Morrell▼ Sell$10K
Kuhn Rebecca▼ Sell$10K
KCK LTD.▼ Sell$16K
KCK LTD.▼ Sell$33K
Martha Morrell▼ Sell$22K
Kuhn Rebecca▼ Sell$22K
Martha Morrell▼ Sell$2K
Kuhn Rebecca▼ Sell$2K
Uri Geiger▲ Buy$12K
Rakhi Kumar▲ Buy$15K
Joseph Lacob▲ Buy$11K
Frank M. Fischer▲ Buy$24K
Martha Morrell▼ Sell$9K
Kuhn Rebecca▼ Sell$9K
Martha Morrell▼ Sell$24K
Kuhn Rebecca▼ Sell$24K
ORBIMED ADVISORS LLC▼ Sell$66K
ORBIMED ADVISORS LLC▼ Sell$124K
ORBIMED ADVISORS LLC▼ Sell$220K
ORBIMED ADVISORS LLC▼ Sell$25K
ORBIMED ADVISORS LLC▼ Sell$311K
Martha Morrell▼ Sell$3K
Kuhn Rebecca▼ Sell$3K
ORBIMED ADVISORS LLC▼ Sell$346K
ORBIMED ADVISORS LLC▼ Sell$256K
ORBIMED ADVISORS LLC▼ Sell$37K
ORBIMED ADVISORS LLC▼ Sell$4K
ORBIMED ADVISORS LLC▼ Sell$197K
ORBIMED ADVISORS LLC▼ Sell$333K
ORBIMED ADVISORS LLC▼ Sell$6.7M
Uri Geiger▲ Buy$12K
Joseph Lacob▲ Buy$11K
Frank M. Fischer▲ Buy$24K
Rakhi Kumar▲ Buy$15K
Martha Morrell▼ Sell$21K
Kuhn Rebecca▼ Sell$17K
Martha Morrell▲ Buy$0
Kuhn Rebecca▲ Buy$0
Joel Becker▲ Buy$0
Martha Morrell▼ Sell$218K
Kuhn Rebecca▼ Sell$172K
Martha Morrell▲ Buy$1K
Martha Morrell▼ Sell$52K
Martha Morrell▼ Sell$213K
Martha Morrell▼ Sell$10K
Martha Morrell▼ Sell$29K
Martha Morrell▲ Buy$5
Martha Morrell▲ Buy$5
Martha Morrell▲ Buy$5
Martha Morrell▲ Buy$318
Martha Morrell▲ Buy$1K
Martha Morrell▼ Sell$170K
Martha Morrell▼ Sell$15
Martha Morrell▼ Sell$12K
Martha Morrell▼ Sell$4K
Kuhn Rebecca▼ Sell$3K
Uri Geiger▲ Buy$12K
Rakhi Kumar▲ Buy$15K
Joseph Lacob▲ Buy$11K
Frank M. Fischer▲ Buy$24K
Martha Morrell▼ Sell$135K
Martha Morrell▼ Sell$1K
Martha Morrell▼ Sell$28K
Martha Morrell▼ Sell$90K
Martha Morrell▼ Sell$12K
Kuhn Rebecca▼ Sell$9K
KCK LTD.▼ Sell$28K
KCK LTD.▼ Sell$64K
KCK LTD.▼ Sell$49K
KCK LTD.▼ Sell$41K
KCK LTD.▼ Sell$58K
Martha Morrell▼ Sell$2K
Kuhn Rebecca▼ Sell$1K
ORBIMED ADVISORS LLC▼ Sell$6K

We use analytics to understand how market-wall is used. No personal data is sold.